Menopause Insomnia: Why You Can’t Sleep and What to Do
Dr. Karla Loken is a board-certified OB/GYN with over two decades of clinical experience and a distinguished career driving innovation in women's health across the pharmaceutical, diagnostics, and medical device industries. Through her consultancy, Loken & Associates, Dr. Loken provides medical affairs expertise and fractional Chief Medical Officer (CMO) services, helping early-stage companies bridge the gap between scientific innovation and industry application. She serves as Chief Medical Officer to MenoHealth. · 13 min read · Sep 2026
Medically reviewed by Karla F. Loken, DO, FACOOG on September 20, 2026
Menopause insomnia: why sleep falls apart in perimenopause, what SWAN data show, and what actually works — from CBT-I to hormone and non-hormonal treatment.
The brain is exquisitely sensitive to estrogen and progesterone. It's had these hormones in a particular pattern its whole life, and now that pattern is broken. That's not a character flaw. That's physiology.
If you’re searching for menopause insomnia, you’ve probably been awake at 2 a.m. enough nights in a row to know this isn’t ordinary “trouble sleeping.” Whether it’s hot flashes waking you, anxiety holding you in light sleep, or a brain that simply won’t switch off at midnight, sleep disruption is one of the most common and most under-treated parts of the menopause transition — and it’s not in your head.
This guide walks through what’s driving menopause insomnia, what the longitudinal data say about how common it is and how long it lasts, and what actually helps — from CBT-I, the first-line treatment for chronic insomnia, to the medications and hormonal options that have a place when behavioral approaches aren’t enough.
Key takeaways
Menopause insomnia is real, common, and biologically grounded. SWAN data show sleep disturbance prevalence rises through perimenopause and stays elevated in postmenopause for many women.
Multiple mechanisms contribute: vasomotor symptoms waking you, declining estrogen and progesterone effects on sleep architecture, mood changes, and the cumulative effect of stress and aging on sleep.
Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment for chronic insomnia in adults — including menopausal women — per major sleep society guidelines, with durable effect.
When CBT-I isn’t enough, options include treating the vasomotor symptoms that fragment sleep (hormone therapy, gabapentin, fezolinetant, others), short-term sleep medications used judiciously, and addressing coexisting mood symptoms.
Sleep apnea risk rises after menopause and can masquerade as insomnia. If you snore, gasp, or feel unrefreshed despite enough time in bed, ask about a sleep study.
The short answer on menopause insomnia
Menopause insomnia is sleep difficulty — falling asleep, staying asleep, or waking too early — that emerges or worsens during the menopause transition and meaningfully affects daytime function. It’s driven by a combination of vasomotor symptoms, hormonal effects on sleep architecture, mood changes, and the broader aging trajectory of sleep.
The most rigorous data come from the Study of Women’s Health Across the Nation (SWAN), whose sleep substudies documented that sleep disturbance prevalence rises substantially through perimenopause and remains elevated in postmenopause. Women with vasomotor symptoms report worse sleep than women without, and the relationship runs in both directions — bad sleep also amplifies the perceived severity of VMS.
Why menopause changes your sleep
Sleep changes during the menopause transition have multiple biological inputs:
I've had problems with perimenopause. And no one's taking me seriously. I'm seeing doctor after doctor and I'm not getting any relief. The same story, over and over again — in real life and on social media.
Vasomotor symptoms. Nighttime hot flashes — night sweats — fragment sleep by waking you, often during REM-rich stages in the back half of the night. The fuller picture is in our guide on menopause night sweats.
Estrogen and progesterone. Declining and fluctuating estrogen affects thermoregulation, mood, and several neurotransmitter systems involved in sleep regulation. Progesterone has direct sedating effects through GABA-A receptors; its decline removes a mild sleep-promoting signal.
Mood. Anxiety and low mood — both more common during the transition per Bromberger and colleagues’ SWAN analysis — independently disrupt sleep. The relationship is bidirectional: bad sleep worsens mood, worse mood worsens sleep.
Sleep architecture aging. Slow-wave sleep declines with age in both sexes; this trajectory accelerates around the menopause transition for many women.
Sleep apnea risk. Obstructive sleep apnea becomes substantially more common after menopause. The hormonal protection women have premenopausally erodes, and weight redistribution toward the abdomen and neck increases mechanical risk. This is the most under-recognized contributor to “menopause insomnia.”
The upshot is that menopause insomnia rarely has a single cause. Identifying which contributors are dominant for you shapes which treatment to try first.
How common menopause insomnia is
In SWAN, sleep disturbance prevalence rose from roughly 30 percent in late premenopause to over 40 percent in late perimenopause and remained elevated into postmenopause, per the Kravitz 2015 longitudinal analysis. Women with persistent vasomotor symptoms reported the worst sleep — significantly worse than women without VMS at the same menopausal stage.
The pattern of sleep difficulty also shifts. Sleep-onset insomnia (trouble falling asleep) is less specifically associated with menopause than sleep-maintenance insomnia (waking and not getting back to sleep). Many women describe the same picture: fall asleep without trouble, wake at 2 or 3 a.m. — often soaked, sometimes not — and then lie there for an hour or two before drifting back into light, unrefreshing sleep.
For more on how long this typically lasts and where you sit in the transition, our pillar guide on how long does menopause last provides the framing.
What actually helps: CBT-I
Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment for chronic insomnia in adults, including menopausal women, per major sleep society guidelines. It’s a structured, time-limited (typically 4 to 8 sessions) protocol with several components:
Sleep restriction therapy to consolidate sleep and rebuild homeostatic drive
Stimulus control to re-pair bed and bedroom with sleep rather than wakefulness
Cognitive restructuring to address the anxious thoughts about sleep that perpetuate insomnia
Sleep hygiene education
The thing I hear most from patients is: 'I don't feel like myself.' There's a beautiful term being used now — NFLM, Not Feeling Like Myself. It captures something the symptom checklists have always missed.
Relaxation training
The evidence base for CBT-I in menopausal women specifically is solid. The benefits are durable — unlike medications, the effect persists after treatment ends. CBT-I doesn’t reduce hot flash frequency, but it improves sleep efficiency and the time spent awake after night-time episodes, which is often the more disabling problem.
CBT-I is increasingly accessible. It can be delivered in person by a trained therapist, through structured programs and apps that have been validated against in-person CBT-I, or as digital CBT-I (dCBT-I) with similar effect sizes. For many women, this is the right first move before turning to medication.
What helps: addressing the cause
CBT-I addresses the maintenance factors of insomnia, but if a hot flash wakes you four times a night, no behavioral intervention is going to fully solve it. Treating the underlying drivers is often the difference-maker.
For VMS-driven sleep disruption: the Menopause Society’s 2022 Hormone Therapy Position Statement supports hormone therapy as first-line for moderate-to-severe vasomotor symptoms in appropriately selected women. Reducing VMS often translates directly into less fragmented sleep — covered in HRT benefits.
Non-hormonal medication for VMS that also helps sleep: gabapentin dosed at bedtime is often preferred when night sweats are the dominant problem, because its sedating effect is useful rather than a problem. The full breakdown is in our medication for hot flashes guide. Fezolinetant (Veozah) is a newer non-hormonal option specifically for VMS — covered in detail in Veozah (fezolinetant).
For mood-driven sleep disruption: treating anxiety and depression often improves sleep substantially. SSRIs and SNRIs at appropriate doses can address both — and several have VMS evidence as well. The interaction is covered in our menopause anxiety guide.
For sleep apnea: a sleep study is the right next step if you snore, gasp, or feel unrefreshed despite sufficient time in bed. Treating apnea — typically with CPAP or oral appliances — can transform sleep in women whose “insomnia” was actually undiagnosed apnea.
What about sleep medications
Short-term sleep medications have a role, used judiciously and in combination with addressing the underlying drivers. Z-drugs (zolpidem, eszopiclone, zaleplon), low-dose doxepin, and selective melatonin-receptor agonists each have evidence and a different side-effect profile. Benzodiazepines are generally avoided for chronic insomnia in this age group given dependence risk, cognitive effects, and fall risk.
Important framing: sleep medications work while you take them. They don’t address the underlying maintenance factors of insomnia. That’s why CBT-I, ideally before or alongside medication, is the more durable strategy. A clinician who actually understands sleep can help you decide which (if any) medication fits your situation and how to use it without creating new problems.
Over-the-counter sleep aids — most of which rely on first-generation antihistamines like diphenhydramine — are widely used and not a good long-term solution. Tolerance develops, daytime grogginess is common, and anticholinergic effects in midlife and older women have been associated with cognitive concerns in observational data. They’re worth knowing about so you can step away from them rather than rely on them.
Sleep hygiene — what’s worth doing, what’s overhyped
Sleep hygiene gets oversold as a stand-alone fix. It rarely is. But several of its components matter, particularly when combined with CBT-I and treatment of underlying drivers:
Consistent wake time, every day. This is the single most important behavioral lever.
Bedroom cool, dark, and quiet. For menopause specifically, slightly cooler than the standard 65–68°F often helps.
Caffeine cutoff by early afternoon. Caffeine’s half-life lengthens with age.
Alcohol off the table close to bedtime. Alcohol fragments sleep and triggers VMS.
Wind-down routine that doesn’t involve a phone in bed.
Bed for sleep and sex, full stop. Reading, scrolling, and worrying in bed retrains the brain to associate bed with wakefulness.
These won’t solve moderate-to-severe menopause insomnia on their own. They reduce the load and amplify the effect of the interventions that actually move the needle.
What this means for you
Three points worth taking forward:
Identify which drivers are dominant. A few weeks of tracking — when you wake, what wakes you, whether you’re soaked, whether your mind is racing, whether you snore — usually points clearly at which underlying factor to treat first.
CBT-I is the first-line treatment. It’s durable, well-studied, and increasingly accessible through digital programs. It’s worth pursuing before turning to medication for chronic insomnia.
Treat the drivers, not just the symptom. If hot flashes are waking you, address the hot flashes. If anxiety is the dominant input, address the anxiety. If you snore, get a sleep study.
When to talk to your doctor
Reasonable triggers for a conversation:
Insomnia that’s persisted more than a few weeks and is affecting daytime function, mood, or work
Snoring, gasping, or unrefreshing sleep despite sufficient time in bed (consider sleep apnea evaluation)
Hot flashes or night sweats waking you regularly
Mood symptoms — anxiety, low mood — that coexist with sleep disruption
Use of over-the-counter sleep aids more than occasionally
A desire to understand whether you’re a candidate for CBT-I, hormone therapy, or non-hormonal medication
If you’d like to prepare, our guide on talking to your doctor about menopause walks through what to bring and what to ask.
Frequently asked questions
Why does menopause cause insomnia?
Multiple mechanisms: vasomotor symptoms waking you, declining estrogen and progesterone affecting sleep architecture, increased mood vulnerability during the transition, and rising risk of obstructive sleep apnea. Most women have more than one contributor.
Will menopause insomnia go away on its own?
For some women, sleep normalizes a year or two after the final period. For many, it doesn’t — SWAN data show sleep disturbance prevalence stays elevated well into postmenopause. “Wait it out” is rarely a sufficient plan when sleep loss is affecting daytime function.
Is CBT-I really better than sleep medication?
For chronic insomnia, yes — CBT-I has durable effect after treatment ends, whereas medications work while you take them. CBT-I is recommended as first-line by major sleep society guidelines, including in menopausal women.
Can hormone therapy help me sleep better?
For women whose insomnia is largely driven by night sweats and other vasomotor symptoms, yes — reducing VMS often translates directly into less fragmented sleep. The benefit is more about treating the underlying disruptor than a direct sleep effect. Discussed in HRT benefits.
Is melatonin helpful for menopause insomnia?
The evidence for melatonin in menopausal women specifically is modest. It’s most useful for circadian-rhythm problems (jet lag, shift work) rather than the sleep-maintenance pattern most common in menopause. The supplement industry is poorly regulated and dosing varies widely between products; lower doses (0.3–1 mg) often work as well as higher.
When should I worry about sleep apnea?
If you snore, your partner has noticed pauses in your breathing, you wake gasping, your sleep doesn’t refresh you despite enough time in bed, or you have other risk factors (higher BMI, larger neck circumference, hypertension), ask your clinician about a sleep study. Sleep apnea risk rises substantially after menopause and is frequently misdiagnosed as insomnia.
Sources
Kravitz HM, Joffe H. Sleep during the perimenopause: a SWAN story. Obstetrics and Gynecology Clinics of North America. 2011;38(3):567-586.
Kravitz HM, Kazlauskaite R, Joffe H. Sleep, health, and metabolism in midlife women and menopause: food for thought. Obstetrics and Gynecology Clinics of North America. 2018;45(4):679-694. (SWAN sleep longitudinal context.)
Bromberger JT, Kravitz HM. Mood and menopause: findings from the Study of Women’s Health Across the Nation (SWAN) over 10 years. Obstetrics and Gynecology Clinics of North America. 2011;38(3):609-625.
The Menopause Society. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
The Menopause Society. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society. Menopause. 2023;30(6):573-590.
Joffe H, Guthrie KA, LaCroix AZ, et al. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Internal Medicine. 2014;174(7):1058-1066. (MsFLASH.)
Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine. 2015;175(4):531-539.
National Institute for Health and Care Excellence. Menopause: identification and management (NG23). Updated November 2024.
Disclaimer
This article is for educational purposes and does not constitute medical advice. Always consult a qualified healthcare provider for guidance on your specific situation. Prescription medications referenced — including hormone therapy, gabapentin, fezolinetant (Veozah), Z-drugs (zolpidem, eszopiclone, zaleplon), low-dose doxepin, SSRIs, and SNRIs — require evaluation by a clinician, have specific contraindications, and may interact with other medications. Do not start, stop, or change a prescription medication without speaking to your clinician.
